NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Renal Dialysis


Return to Library

Free Renal Dialysis Articles


Reports outline angioplasty study results from University of Lausanne



2009 AUG 24 - (NewsRx.com) -- According to a study from Lausanne, Switzerland, "A method for hemodialysis catheter placement in patients with central thoracic venous stenosis or occlusion is described and initial results are analyzed. Twelve patients, with a mean age of 63.2 years (42-80 years), with central venous stenosis or occlusion, and who required a hemodialysis catheter were reviewed."

"All lesions were confirmed by helical CT or phlebography. Five patients had stenosis while seven patients were diagnosed with an occlusion of thoracic central veins. All patients were asymptomatic, without sign of superior vena cava syndrome. After percutaneous transstenotic catheterization or guidewire-based recannalization in occlusions, a balloon dilatation was performed and a stent was placed, when necessary, prior to catheter placement. Technical success was 92%. Three patients had angioplasty alone and nine patients had angioplasty with stent placement. Dialysis catheters were successfully inserted through all recannalized accesses. No immediate complication occurred, nor did any patient develop superior vena cava syndrome after the procedure. The mean follow-up was 21.8 months (range, 8-48 months). Three patients developed a catheter dysfunction with fibrin sheath formation (at 7, 11, and 12 months after catheter placement, respectively). Two were successfully managed by percutaneous endovascular approach and one catheter was removed," wrote C. Haller and colleagues, University of Lausanne.

The researchers concluded: "For patients with central venous stenosis or occlusion and those who need a hemodialysis catheter, catheter insertion can be reliably achieved immediately after endovascular recannalization with acceptable technical and long-term success rates. This technique should be considered as an alternative procedure for placing a new hemodialysis catheter through a patent vein.."

Haller and colleagues published their study in Cardiovascular and Interventional Radiology (Placement of Hemodialysis Catheters Through Stenotic or Occluded Central Thoracic Veins. Cardiovascular and Interventional Radiology, 2009;32(4):695-702).

For more information, contact S.D. Qanadli, CHUV University Lausanne, Dept. of Radiol, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.

Publisher contact information for the journal Cardiovascular and Interventional Radiology is: Springer, 233 Spring St., New York, NY 10013, USA.

Keywords: Switzerland, Lausanne, Angiology, Angioplasty, Cardiology, Cardiovascular, Catheterization, Dialysis Catheter, Hemodialysis, Medical Device, Radiology, Renal Dialysis, Stenosis, Superior Vena Cava Syndrome, University of Lausanne.

This article was prepared by Cardiovascular Week editors from staff and other reports. Copyright 2009, Cardiovascular Week via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login